Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01FA10	ARATRO	G	Azithromycin - 500mg	500mg	Tablet, film coated	485,127 L.L
J01FA10	AZICIN 500 BENTA	G	Azithromycin - 500mg	500mg	Tablet, film coated	573,373 L.L
J01FA10	AZM-500	G	Azithromycin - 500mg	500mg	Tablet, film coated	448,843 L.L
N07CA01	ALVIGO	G	Betahistine dihydrochloride - 16mg	16mg	Tablet, scored	1,204,339 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg	100mg	Injectable concentrated solution	24,533,456 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 100mg/4ml	100mg/4ml	Injectable concentrated solution	24,533,456 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg	400mg	Injectable concentrated solution	75,875,312 L.L
L01FG01	AVASTIN	BioTech	Bevacizumab - 400mg/16ml	400mg/16ml	Injectable concentrated solution	75,875,312 L.L
C07AB07	APO-BISOPROLOL	G	Bisoprolol fumarate - 5mg	5mg	Tablet	923,220 L.L
L01XG01	ALVOCADE	G	Bortezomib - 3.5mg	3.5mg	Injectable powder for solution	14,169,600 L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	L.L
L01FX05	ADCETRIS	BioTech	Brentuximab Vedotin - 50mg	50mg	Injectable powder for concentrate for solution	298,266,862 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 180mg	180mg	Tablet, film coated	493,595,998 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 30mg	30mg	Tablet, film coated	124,685,776 L.L
L01ED04	ALUNBRIG	B	Brigatinib - 90mg	90mg	Tablet, film coated	374,059,747 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 0.1%	0.15%	Drops solution	999,819 L.L
S01EA05	ALPHANOVA	G	Brimonidine tartrate - 0.15%	0.15%	Drops solution	599,354 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
S01EC04	AZOPT	B	Brinzolamide - 10mg/ml	10mg/ml	Drops suspension	804,962 L.L
N05BA08	ANXYL	G	Bromazepam - 3mg	3mg	Tablet, scored	167,660 L.L
R03BA02	AERONIDE	G	Budesonide - 200mcg	200mcg	Capsule, inhalation	1,150,329 L.L
R03BA02	AERONIDE	G	Budesonide - 400mcg	400mcg	Capsule, inhalation	2,116,552 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 16mg	16mg	Tablet	705,517 L.L
C09CA06	ANDESART 16	G	Candesartan cilexetil - 16mg	16mg	Tablet	665,202 L.L
C09CA06	ARKANDA 16	G	Candesartan cilexetil - 16mg	16mg	Tablet	639,925 L.L
C09DA06	ATACAND PLUS	B	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg		Tablet	705,517 L.L
C09DA06	ARKANDA PLUS 16/12.5	G	Candesartan cilexetil - 16mg, Hydrochlorothiazide - 12.5mg	32mg	Tablet	642,485 L.L
C09CA06	ATACAND	B	Candesartan cilexetil - 8mg	8mg	Tablet	526,786 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L

...